根据美国证券交易委员会（SEC）最新披露的文件，iRhythm Technologies Inc.与Baxter公司已达成协议，相互授予对方心脏监测传感器专利的免版税许可。这一举措，意味着两家企业能够在无需支付专利使用费的前提下，自由使用对方在心脏监测传感器领域的相关专利技术。通过这种互惠互利的安排，双方均有望加速各自产品的研发进程，并进一步巩固其在心脏监测技术市场的竞争地位。该协议的签署，无疑是两家公司在医疗科技领域合作的一次重要深化。
根据美国证券交易委员会（SEC）最新披露的文件，iRhythm Technologies Inc.与Baxter公司已达成协议，相互授予对方心脏监测传感器专利的免版税许可。这一举措，意味着两家企业能够在无需支付专利使用费的前提下，自由使用对方在心脏监测传感器领域的相关专利技术。通过这种互惠互利的安排，双方均有望加速各自产品的研发进程，并进一步巩固其在心脏监测技术市场的竞争地位。该协议的签署，无疑是两家公司在医疗科技领域合作的一次重要深化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.